Home » Topics » Regulatory » Patents

Patents
RSS

Basilea Pharmaceutica patents MAPK inhibitors

Aug. 25, 2016

FORMA Therapeutics describes HDAC inhibitors

Aug. 24, 2016

FORMA Therapeutics patents HDAC 6 inhibitors

Aug. 23, 2016

Sanford-Burnham Medical Research Institute reports glucocorticoid receptor translocation inhibitors

Aug. 23, 2016

Novo Nordisk divulges neuropeptide Y receptor agonists

Aug. 23, 2016

Trillium Therapeutics patents EGFR inhibitors

Aug. 23, 2016

FORMA Therapeutics discloses ubiquitin hydrolase inhibitors

Aug. 23, 2016

Chinese scientists present Nav1.7 channel blockers

Aug. 22, 2016

Cancer Research Technology develops ENPP2 inhibitors

Aug. 22, 2016

Bayer Pharma discloses sGC activators

Aug. 22, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...